📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling. (2017)

First Author: Karwi QG

Attributed to: Precision Medicine Exeter Innovation Platform (PMEI Platform): Proof of Concept Funds funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.13688

PubMed Identifier: 27930802

Publication URI: http://europepmc.org/abstract/MED/27930802

Type: Journal Article/Review

Volume: 174

Parent Publication: British journal of pharmacology

Issue: 4

ISSN: 0007-1188